Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-04 Purchase |
2024-03-05 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks |
43,360 | $11.35 | $492,028 | 43,360 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-24 Option Award |
2025-01-28 4:15 pm |
N/A 2035-01-23 |
Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks |
582,000 | $0 | 582,000 (Direct) |
View |
| 2024-07-03 Exercise |
2024-07-08 08:00 am |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks |
150,000 | $3.27 | 2,473,760 (Direct) |
View |
| 2024-07-03 Exercise |
2024-07-08 08:00 am |
N/A 2033-05-11 |
Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks |
150,000 | $0 | 2,473,760 (Direct) |
View |
Ownership |
2023-07-03 4:16 pm |
N/A 2033-05-11 |
Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks |
0 | $0 | 2,430,400 (Direct) |
View |
| 2023-05-19 Exercise |
2023-05-19 4:17 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sapir Alex Director |
3,750 | $0 | 3,750 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:45 pm |
N/A 2032-05-18 |
PhaseBio Pharmaceuticals Inc | PHAS | Sapir Alex Director |
21,250 | $0 | 21,250 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 6:14 pm |
N/A 2031-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Sapir Alex Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 6:39 pm |
N/A 2030-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Sapir Alex Director |
4,909 | $0 | 4,909 (Direct) |
View |